-
Mashup Score: 16
T-cell therapies, such as chimeric antigen receptor (CAR) T-cell, bispecific T-cell engager (BiTE) and tumor-infiltrating lymphocyte (TIL) therapies, …
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
Oral and Poster Abstracts Oral 653. Myeloma and Plasma Cell Dyscrasias: Prospective Therapeutic Trials: Novel Drugs and Optimized Approaches in Myeloma Biological therapies, Research, clinical trials, Bispecific Antibody Therapy, Clinical Research, Plasma Cell Disorders, drug development, Diseases, Therapies, Immunotherapy, Lymphoid Malignancies Suzanne…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Pretreatment with tocilizumab prior to cevostamab in patients with RRMM ⬇️CRS (35.7% vs 90.9%) ✅No difference in response rate #mmsm #BiTe #ASH22 https://t.co/9TXw2oOyYe https://t.co/jOuXXIyJpV
-
-
Mashup Score: 12NK cell-based cancer immunotherapy: from basic biology to clinical development - Journal of Hematology & Oncology - 3 year(s) ago
Natural killer (NK) cell is a specialized immune effector cell type that plays a critical role in immune activation against abnormal cells. Different from events required for T cell activation, NK cell activation is governed by the interaction of NK receptors with target cells, independent of antigen processing and presentation. Due to relatively unsophisticated cues for activation, NK cell has…
Source: Journal of Hematology & OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
On Deck: NK cell-based cancer immunotherapy: from basic biology to clinical development | Journal of Hematology & Oncology | Full Text #biotwitter #CarTcell #BiTe #leuksm #gbm https://t.co/lXrUiO9ZkJ
-
-
Mashup Score: 0Melissa L. Johnson, MD @MLJohnsonMD2 @SarahRCannon #AMG - 3 year(s) ago
Melissa L. Johnson, MD from Sarah Cannon Cancer Center speaks about A phase 1 study of AMG 757, a half-life extended bispecific T-cell engager (BiTE®) imm
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A phase 1 study of AMG 757 Melissa L. Johnson, MD @MLJohnsonMD2 @SarahRCannon #AMG757 #BiTE #SCLC #LungCancer #Cancer #Research Link To FULL Video: https://t.co/LQ1vjoEDMa https://t.co/OPIETWAxDg
-
-
Mashup Score: 16Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - 4 year(s) ago
Single-cell RNA sequencing analysis shows that CD19, primarily considered as a B cell-specific surface antigen, is expressed in human brain mural cells that are critical for blood-brain-barrier integrity, suggesting that this cell population may contribute to the neurotoxicity of CD19-directed immunotherapy including CAR-T.
Source: CellCategories: Future of Medicine, Latest HeadlinesTweet-
Neat! Single-cell RNA sequencing shows #CD19 expression in brain mural cells that could explain #neurotoxicity of #immunotherapy by #CART cells or #BiTE antibodies, article in @CellPressNews by @Satpathology @IAmDrDex @HowardYChang @carlhjune! https://t.co/NStwgrqbUH https://t.co/Vv2OOwSdq5
-
Our comprehensive review and insight into Cardiotoxicity of T-Cell Antineoplastic Therapies #CART, #BiTE, #TIL #CardioOnc @JACCJournals @SaurabhSDani @datsunian @vgzmd #AnjuNohria #cardioonc https://t.co/FSmOk1CIQB https://t.co/ZqG1LLYcCV